Zhou H - Search Results

1

Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer.

Chen Y, Zhou H, Wang Z, Huang Z, Wang J, Zheng M, Ni X, Liu L. Chen Y, et al. Among authors: zhou h. Biosci Rep. 2021 May 28;41(5):BSR20203804. doi: 10.1042/BSR20203804. Biosci Rep. 2021. PMID: 33960364 Free PMC article.

2

A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.

Zhou H, Zhang H, Shi M, Wang J, Huang Z, Shi J. Zhou H, et al. Int Immunopharmacol. 2020 Nov;88:106856. doi: 10.1016/j.intimp.2020.106856. Epub 2020 Aug 7. Int Immunopharmacol. 2020. PMID: 32777677

3

Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.

Chen Y, Wang J, Zhou H, Huang Z, Qian L, Shi W. Chen Y, et al. Among authors: zhou h. Biomed Res Int. 2021 Jun 10;2021:6628391. doi: 10.1155/2021/6628391. eCollection 2021. Biomed Res Int. 2021. PMID: 34222478 Free PMC article.

4

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.

Zhou H, Zheng M, Shi M, Wang J, Huang Z, Zhang H, Zhou Y, Shi J. Zhou H, et al. Among authors: zhou y. BMC Cancer. 2021 Aug 20;21(1):938. doi: 10.1186/s12885-021-08655-1. BMC Cancer. 2021. PMID: 34416861 Free PMC article.

5

Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration.

Zhou H, Bian T, Qian L, Zhao C, Zhang W, Zheng M, Zhou H, Liu L, Sun H, Li X, Zhang J, Liu Y. Zhou H, et al. Pathol Res Pract. 2021 Dec;228:153680. doi: 10.1016/j.prp.2021.153680. Epub 2021 Nov 3. Pathol Res Pract. 2021. PMID: 34798483 Free article.

6

Prognostic signature of lung adenocarcinoma based on stem cell-related genes.

Huang Z, Shi M, Zhou H, Wang J, Zhang HJ, Shi J-. Huang Z, et al. Among authors: zhou h. Sci Rep. 2021 Jan 18;11(1):1687. doi: 10.1038/s41598-020-80453-4. Sci Rep. 2021. PMID: 33462260 Free PMC article.

7

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma.

Wang Z, Zhu J, Wang T, Zhou H, Wang J, Huang Z, Zhang H, Shi J. Wang Z, et al. Among authors: zhou h. Front Oncol. 2021 Jul 16;11:639724. doi: 10.3389/fonc.2021.639724. eCollection 2021. Front Oncol. 2021. PMID: 34336646 Free PMC article.

8

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.

Sun G, Wang T, Shi M, Zhou H, Wang J, Huang Z, Zhang H, Shi J. Sun G, et al. Among authors: zhou h. Ann Transl Med. 2021 Jul;9(13):1057. doi: 10.21037/atm-21-36. Ann Transl Med. 2021. PMID: 34422969 Free PMC article.

9

Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.

Zhu J, Jiang Y, Wang T, Wu A, Zhou T, Zhang A, Tang Y, Shen Z, Wang J, Zhou H, Shi J, Chen J. Zhu J, et al. Among authors: zhou h, zhou t. Dis Markers. 2022 Feb 9;2022:2989200. doi: 10.1155/2022/2989200. eCollection 2022. Dis Markers. 2022. PMID: 35186164 Free PMC article.

10

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration.

Wang J, Shi M, Zhang H, Zhou H, Huang Z, Zhou Y, Shi J. Wang J, et al. Among authors: zhou h, zhou y. Thorac Cancer. 2022 Jun;13(12):1837-1849. doi: 10.1111/1759-7714.14466. Epub 2022 May 13. Thorac Cancer. 2022. PMID: 35567329 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,791 results

Search Page

Filters